
May 12 (Reuters) - Valneva SE VLS.PA:
PROVIDES UPDATE ON RECOMMENDED USE OF IXCHIQ® BY ELDERLY INDIVIDUALS IN THE UNITED STATES
FDA AND CDC RECOMMEND IXCHIQ USE FOR AGES 18 TO 60
EMA TEMPORARILY SUSPENDS IXCHIQ VACCINE FOR INDIVIDUALS OVER 65
FDA AND CDC RECOMMEND PAUSE IN USE OF VALNEVA'S CHIKUNGUNYA VACCINE IN ELDERLY